• DOI:10.1517/14656566.2012.742887
Corpus ID: 25769557

Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz

@article{Dabaghzadeh2012PotentialBO,
  title={Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz},
  author={Fatemeh Dabaghzadeh and H. Khalili and Padideh Ghaeli and S. Dashti-Khavidaki},
  journal={Expert Opinion on Pharmacotherapy},
  year={2012},
  volume={13},
  pages={2613 - 2624}
}

• Fatemeh Dabaghzadeh, H. Khalili, +1 author S. Dashti-Khavidaki
• Published 2012
• Medicine
• Expert Opinion on Pharmacotherapy

Introduction: More than 50% of HIV-positive patients experience neuropsychiatric adverse reactions following efavirenz therapy. Discontinuation of efavirenz due to its neuropsychiatric side effects has been reported in 2 – 13% of patients. Dizziness, headache, nightmares, abnormal dreams, mild cognitive difficulty, sleep disturbance (somnolence and insomnia), impaired concentration, depression, hallucination, delusion, paranoia, anxiety, agitation, aggressive behavior, mania, emotional… Expand

View on Taylor & Francis

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed